Healthpeak Properties, Inc.

NYSE:DOC Stock Report

Market Cap: US$14.5b

Healthpeak Properties Future Growth

Future criteria checks 0/6

Healthpeak Properties's earnings are forecast to decline at 16.2% per annum while its annual revenue is expected to grow at 5.8% per year. EPS is expected to decline by 17.2% per annum. Return on equity is forecast to be 2.3% in 3 years.

Key information

-16.2%

Earnings growth rate

-17.2%

EPS growth rate

Health Care REITs earnings growth20.4%
Revenue growth rate5.8%
Future return on equity2.3%
Analyst coverage

Good

Last updated01 Jan 2025

Recent future growth updates

Recent updates

Healthpeak Properties: I'm Buying The 6% Dividend Yield

Dec 22

Healthpeak: Potential Upside Still Exists, But Don't Expect Much

Oct 21

Healthpeak: Missing The Boat Above $20/Share

Jul 18

Healthpeak Properties: A 6.1% Yielding Healthcare Trust With Upside

Jul 09

Healthpeak Q1 - The "Best" In The Space With A 15% Upside

May 14

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Apr 12

Healthpeak Properties: Undervalued With Strong Fundamentals

Feb 22

Healthpeak Opportunistically Cheap As Supply Moderates

Dec 13

Healthpeak Properties: 7.2% Yielding SWAN

Oct 29

Healthpeak Properties: A Safe 6.9% Yield

Oct 17

Healthpeak Is Both Undervalued And Undercovered - And A 'Buy'

Aug 10

Healthpeak Properties: 6% Yield, Profit From Market Absurdity

Jul 06

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Feb 07

Healthpeak Properties declares $0.30 dividend

Feb 01

Healthpeak prices $400M notes offering

Jan 09

Healthpeak Properties Q3 2022 Earnings Preview

Oct 31

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Sep 19

Healthpeak Properties: There Are Still Better Prospects Right Now

Jul 06

Earnings and Revenue Growth Forecasts

NYSE:DOC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20273,0761676421,5512
12/31/20262,9581756181,4658
12/31/20252,8361576731,38910
12/31/20242,6712787071,31610
9/30/20242,5563091,0181,018N/A
6/30/20242,412287953953N/A
3/31/20242,262193935935N/A
12/31/20232,181304956956N/A
9/30/20232,152239932932N/A
6/30/20232,116530922922N/A
3/31/20232,088543880880N/A
12/31/20222,061495900900N/A
9/30/20222,020514917917N/A
6/30/20221,981213885885N/A
3/31/20221,939312867867N/A
12/31/20211,896117795795N/A
9/30/20211,84568790790N/A
6/30/20211,787-17798798N/A
3/31/20211,719-125786786N/A
12/31/20201,645144758758N/A
9/30/2020988326757757N/A
6/30/20201,102311785785N/A
3/31/20201,185240783783N/A
12/31/20191,240159846846N/A
9/30/20191,908831844844N/A
6/30/20191,826976790790N/A
3/31/20191,8041,080811811N/A
12/31/20181,191822849849N/A
9/30/20181,848169842842N/A
6/30/20181,84662N/A855N/A
3/31/20181,835-8N/A850N/A
12/31/20171,848413N/A847N/A
9/30/20171,945549N/A853N/A
6/30/20172,022599N/A979N/A
3/31/20172,101774N/A1,139N/A
12/31/20162,129361N/A1,214N/A
9/30/20161,655384N/A1,353N/A
6/30/20161,781456N/A1,295N/A
3/31/20161,850427N/A1,261N/A
12/31/20151,940139N/A1,216N/A
9/30/20152,478235N/A1,233N/A
6/30/20152,418367N/A1,235N/A
3/31/20152,347421N/A1,232N/A
12/31/20141,637255N/A1,249N/A
9/30/20142,193927N/A1,188N/A
6/30/20142,143903N/A1,185N/A
3/31/20142,119895N/A1,182N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DOC's earnings are forecast to decline over the next 3 years (-16.2% per year).

Earnings vs Market: DOC's earnings are forecast to decline over the next 3 years (-16.2% per year).

High Growth Earnings: DOC's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DOC's revenue (5.8% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: DOC's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DOC's Return on Equity is forecast to be low in 3 years time (2.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:45
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Healthpeak Properties, Inc. is covered by 41 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jacob KilsteinArgus Research Company
David RodgersBaird
Adam FeinsteinBarclays